▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Cory Renauer

TMFang4apples

Cory Renauer is a contributing Healthcare Analyst at The Motley Fool, covering publicly traded companies across pharmaceuticals, biotechnology, and medical devices. Prior to The Motley Fool, Cory was an educator in Thailand and a laboratory technician for the American Red Cross. He holds a B.S. in Biology from Oakland University. Fun fact: Cory has a collection of novelty socks featuring famous stock market symbols and iconic investor quotes.

Recent Articles by Cory Renauer

a-person-sitting-at-their-home-office-desk-using-a-laptop-computer-getty

Jul 14, 2024 by Cory Renauer

3 High-Yield Dividend Stocks That Still Look Like Bargains

The prices of these reliable dividend payers haven't kept pace with the frothy stock market.

investment-presentation2-getty

Jul 10, 2024 by Cory Renauer

Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.

These three dividend payers could deliver buckets of passive income to patient investors.

smart-investor-making-decisions-getty

Jul 9, 2024 by Cory Renauer

3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now

After underperforming the benchmark index these stocks offer high dividend yields that are hard to ignore.

smart-investor-looking-for-stocks-to-buy-getty

Jul 8, 2024 by Cory Renauer

Billionaires Are Buying Up Beaten-Down AT&T Stock. Should Dividend-Seeking Investors Follow Their Lead?

The telecom giant hasn't increased its dividend in a couple of years, but steady raises could be around the corner.

wall-street-analyst-getty

Jul 8, 2024 by Cory Renauer

Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?

Shares of the world's largest drugmaker offer a dividend yield above 6% at recent prices.

investors-evaluating-a-stock-purchase-getty

Jul 7, 2024 by Cory Renauer

The 2 Highest-Yielding Dividend Stocks in the Dow Jones Offer More Than 5%. Is It Time to Buy?

A telecom provider and a chemicals company provide a higher yield than any other Dow Jones Industrial Average components.

dividend-investor-4-getty

Jul 6, 2024 by Cory Renauer

3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July

Adding these dividend payers to your portfolio is a nearly certain way to boost your passive income stream.

investor-looks-at-financial-chart-on-laptop-getty.

Jul 2, 2024 by Cory Renauer

Roaring Kitty Has a Big Chewy Position. Is It Time to Buy, Sell, or Hold the Stock?

Here's what Keith Gill's recently disclosed Chewy stake could mean for existing shareholders.

individual-investors-at-home-getty

Jul 1, 2024 by Cory Renauer

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July

These reliable dividend payers are no-brainer buys right now.

investor-with-computer-getty

Jun 30, 2024 by Cory Renauer

2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?

With an average dividend yield of about 9.8% at recent prices, even a small investment in these stocks could significantly boost your passive income stream.

investor-charts-closeup-getty

Jun 30, 2024 by Cory Renauer

Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?

After falling a long way, the pharmacy stock is trading at a surprisingly low valuation.

wall-street-analyst-with-laptop-getty

Jun 27, 2024 by Cory Renauer

2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

High yields that could continue growing for the foreseeable future make these stocks no-brainer buys right now.

investment-advisor-with-client-getty

Jun 25, 2024 by Cory Renauer

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

Above-average yields and reliable cash flows make these dividend-paying stocks an income-seeking investor's dream come true.

individual-investor-devices-getty

Jun 25, 2024 by Cory Renauer

Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.

a-person-delivering-a-presentation-getty

Jun 23, 2024 by Cory Renauer

Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks

It doesn't take much to boost your passive income stream with these top dividend-paying stocks.

investor-dark-room-devices-getty

Jun 22, 2024 by Cory Renauer

3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold

The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields.

investor-looking-at-stock-prices-getty

Jun 20, 2024 by Cory Renauer

Down 84%, Is Docusign a Buy on the Dip?

Strong cash flow is encouraging, but decelerating growth is deeply troubling.

TMF-warren-buffett-4-tmf-may-2014

Jun 18, 2024 by Cory Renauer

Warren Buffett Holds $175 Billion of His Portfolio in 2 Stocks That Could Rise 13% and 29% According to a Pair of Wall Street Analysts

Investors who want to reap Buffett-sized returns should understand his biggest investment decisions.

investor-stock-charts-screens-getty

Jun 16, 2024 by Cory Renauer

Soaring Adobe Stock Could Still Climb About 33%, According to 1 Wall Street Analyst. Is It Time to Buy?

Generative artificial intelligence is driving growth now, but is it enough to justify a high stock market valuation?

investor-checking-stocks-getty

Jun 15, 2024 by Cory Renauer

3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services